Evidence map›Paper›PMID 36035887›Full record

ArticleBiomicrofluidics2022

Microfluidic synthesis as a new route to produce novel functional materials.

Xinying Xie, Yisu Wang, Sin-Yung Siu, Chiu-Wing Chan, Yujiao Zhu, Xuming Zhang, Jun Ge, Kangning Ren

Abstract read
In one paragraph

Article in Biomicrofluidics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinying XieDepartment of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China.ORCID 0000-0002-0679-7570
Yisu WangDepartment of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China.
Sin-Yung SiuDepartment of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China.ORCID 0000-0002-9378-0506
Chiu-Wing ChanDepartment of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China.ORCID 0000-0002-3124-0133
Xuming ZhangDepartment of Applied Physics, Hong Kong Polytechnic University, Hong Kong 999077, China.ORCID 0000-0002-9326-5547

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By geometrically constraining fluids into the sub-millimeter scale, microfluidics offers a physical environment largely different from the macroscopic world, as a result of the significantly enhanced surface effects. This environment is characterized by laminar flow and inertial particle behavior, short diffusion distance, and largely enhanced heat exchange. The recent two decades have witnessed the rapid advances of microfluidic technologies in various fields such as biotechnology; analytical science; and diagnostics; as well as physical, chemical, and biological research. On the other hand, one additional field is still emerging. With the advances in nanomaterial and soft matter research, there have been some reports of the advantages discovered during attempts to synthesize these materials on microfluidic chips. As the formation of nanomaterials and soft matters is sensitive to the environment where the building blocks are fed, the unique physical environment of microfluidics and the effectiveness in coupling with other force fields open up a lot of possibilities to form new products as compared to conventional bulk synthesis. This Perspective summarizes the recent progress in producing novel functional materials using microfluidics, such as generating particles with narrow and controlled size distribution, structured hybrid materials, and particles with new structures, completing reactions with a quicker rate and new reaction routes and enabling more effective and efficient control on reactions. Finally, the trend of future development in this field is also discussed.

Identifiers

PMID36035887
PMCPMC9410731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.